Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) mRNA Vaccines & Therapeutics Market 2018, Forecast to 2023
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
SCOPE OF THE REPORT:
This report focuses on the mRNA Vaccines & Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.
The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.
The worldwide market for mRNA Vaccines & Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe mRNA Vaccines & Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of mRNA Vaccines & Therapeutics, with sales, revenue, and price of mRNA Vaccines & Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of mRNA Vaccines & Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
SCOPE OF THE REPORT:
This report focuses on the mRNA Vaccines & Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.
The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.
The worldwide market for mRNA Vaccines & Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Moderna Therapeutics
- CureVac
- Translate Bio
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- eTheRNA
- Ethris
- Tiba Biotechnology
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Standardization Of Cancer Treatment MRNA Vaccine
- Individualized Cancer Treatment MRNA Vaccine
- Infectious Disease Treatment MRNA Vaccine
- Infection Prevention MRNA Vaccine
- Infectious Disease
- Cancer
- Other
Chapter 1, to describe mRNA Vaccines & Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of mRNA Vaccines & Therapeutics, with sales, revenue, and price of mRNA Vaccines & Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of mRNA Vaccines & Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 mRNA Vaccines & Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Standardization Of Cancer Treatment MRNA Vaccine
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Market Analysis by Applications
1.3.1 Infectious Disease
1.3.2 Cancer
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Moderna Therapeutics
2.1.1 Business Overview
2.1.1.1 Moderna Therapeutics Description
2.1.1.2 Moderna Therapeutics Headquarter, Main Business and Finance Overview
2.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Introduction
2.1.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.1.2.2 mRNA Vaccines & Therapeutics Product Information
2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Moderna Therapeutics mRNA Vaccines & Therapeutics Market Share in 2017
2.2 CureVac
2.2.1 Business Overview
2.2.1.1 CureVac Description
2.2.1.2 CureVac Headquarter, Main Business and Finance Overview
2.2.2 CureVac mRNA Vaccines & Therapeutics Product Introduction
2.2.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.2.2.2 mRNA Vaccines & Therapeutics Product Information
2.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global CureVac mRNA Vaccines & Therapeutics Market Share in 2017
2.3 Translate Bio
2.3.1 Business Overview
2.3.1.1 Translate Bio Description
2.3.1.2 Translate Bio Headquarter, Main Business and Finance Overview
2.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Introduction
2.3.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.3.2.2 mRNA Vaccines & Therapeutics Product Information
2.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Translate Bio mRNA Vaccines & Therapeutics Market Share in 2017
2.4 BioNTech
2.4.1 Business Overview
2.4.1.1 BioNTech Description
2.4.1.2 BioNTech Headquarter, Main Business and Finance Overview
2.4.2 BioNTech mRNA Vaccines & Therapeutics Product Introduction
2.4.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.4.2.2 mRNA Vaccines & Therapeutics Product Information
2.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global BioNTech mRNA Vaccines & Therapeutics Market Share in 2017
2.5 Sangamo Therapeutics
2.5.1 Business Overview
2.5.1.1 Sangamo Therapeutics Description
2.5.1.2 Sangamo Therapeutics Headquarter, Main Business and Finance Overview
2.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Introduction
2.5.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.5.2.2 mRNA Vaccines & Therapeutics Product Information
2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Sangamo Therapeutics mRNA Vaccines & Therapeutics Market Share in 2017
2.6 Argos Therapeutics
2.6.1 Business Overview
2.6.1.1 Argos Therapeutics Description
2.6.1.2 Argos Therapeutics Headquarter, Main Business and Finance Overview
2.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Introduction
2.6.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.6.2.2 mRNA Vaccines & Therapeutics Product Information
2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Argos Therapeutics mRNA Vaccines & Therapeutics Market Share in 2017
2.7 In-Cell-Art
2.7.1 Business Overview
2.7.1.1 In-Cell-Art Description
2.7.1.2 In-Cell-Art Headquarter, Main Business and Finance Overview
2.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Introduction
2.7.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.7.2.2 mRNA Vaccines & Therapeutics Product Information
2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global In-Cell-Art mRNA Vaccines & Therapeutics Market Share in 2017
2.8 eTheRNA
2.8.1 Business Overview
2.8.1.1 eTheRNA Description
2.8.1.2 eTheRNA Headquarter, Main Business and Finance Overview
2.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Introduction
2.8.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.8.2.2 mRNA Vaccines & Therapeutics Product Information
2.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global eTheRNA mRNA Vaccines & Therapeutics Market Share in 2017
2.9 Ethris
2.9.1 Business Overview
2.9.1.1 Ethris Description
2.9.1.2 Ethris Headquarter, Main Business and Finance Overview
2.9.2 Ethris mRNA Vaccines & Therapeutics Product Introduction
2.9.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.9.2.2 mRNA Vaccines & Therapeutics Product Information
2.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Ethris mRNA Vaccines & Therapeutics Market Share in 2017
2.10 Tiba Biotechnology
2.10.1 Business Overview
2.10.1.1 Tiba Biotechnology Description
2.10.1.2 Tiba Biotechnology Headquarter, Main Business and Finance Overview
2.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Introduction
2.10.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.10.2.2 mRNA Vaccines & Therapeutics Product Information
2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Tiba Biotechnology mRNA Vaccines & Therapeutics Market Share in 2017
3 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET COMPETITION, BY MANUFACTURER
3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global mRNA Vaccines & Therapeutics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2017
3.4.2 Top 5 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET ANALYSIS BY REGIONS
4.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global mRNA Vaccines & Therapeutics Sales by Regions (2013-2018)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Regions (2013-2018)
4.2 North America mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.5 South America mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA MRNA VACCINES & THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
5.1.2 North America mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
5.1.3 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
5.1.4 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
5.1.5 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
5.2 North America mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
5.2.2 North America mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
5.3 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
5.3.2 North America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
5.4 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
5.4.2 North America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
6 EUROPE MRNA VACCINES & THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
6.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
6.1.3 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.4 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.5 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.6 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.7 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.2 Europe mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
6.2.2 Europe mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
6.3 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
6.3.2 Europe mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
6.4 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
6.4.2 Europe mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC MRNA VACCINES & THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
7.1.3 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.4 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.5 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.6 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA MRNA VACCINES & THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
8.1.2 South America mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
8.1.3 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
8.1.4 Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
8.1.5 Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
8.2 South America mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
8.2.2 South America mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
8.3 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
8.3.2 South America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
8.4 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
8.4.2 South America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA MRNA VACCINES & THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
9.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.4 UAE mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.5 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.6 Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.7 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET SEGMENT BY TYPE
10.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Standardization Of Cancer Treatment MRNA Vaccine Sales Growth and Price
10.2.1 Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)
10.2.2 Global Standardization Of Cancer Treatment MRNA Vaccine Price (2013-2018)
10.3 Individualized Cancer Treatment MRNA Vaccine Sales Growth and Price
10.3.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)
10.3.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2013-2018)
10.4 Infectious Disease Treatment MRNA Vaccine Sales Growth and Price
10.4.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2013-2018)
10.4.2 Global Infectious Disease Treatment MRNA Vaccine Price (2013-2018)
10.5 Infection Prevention MRNA Vaccine Sales Growth and Price
10.5.1 Global Infection Prevention MRNA Vaccine Sales Growth (2013-2018)
10.5.2 Global Infection Prevention MRNA Vaccine Price (2013-2018)
11 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET SEGMENT BY APPLICATION
11.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2013-2018)
11.2 Infectious Disease Sales Growth (2013-2018)
11.3 Cancer Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 MRNA VACCINES & THERAPEUTICS MARKET FORECAST (2018-2023)
12.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.2 Europe mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2018-2023)
12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 mRNA Vaccines & Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Standardization Of Cancer Treatment MRNA Vaccine
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Market Analysis by Applications
1.3.1 Infectious Disease
1.3.2 Cancer
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Moderna Therapeutics
2.1.1 Business Overview
2.1.1.1 Moderna Therapeutics Description
2.1.1.2 Moderna Therapeutics Headquarter, Main Business and Finance Overview
2.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Introduction
2.1.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.1.2.2 mRNA Vaccines & Therapeutics Product Information
2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Moderna Therapeutics mRNA Vaccines & Therapeutics Market Share in 2017
2.2 CureVac
2.2.1 Business Overview
2.2.1.1 CureVac Description
2.2.1.2 CureVac Headquarter, Main Business and Finance Overview
2.2.2 CureVac mRNA Vaccines & Therapeutics Product Introduction
2.2.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.2.2.2 mRNA Vaccines & Therapeutics Product Information
2.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global CureVac mRNA Vaccines & Therapeutics Market Share in 2017
2.3 Translate Bio
2.3.1 Business Overview
2.3.1.1 Translate Bio Description
2.3.1.2 Translate Bio Headquarter, Main Business and Finance Overview
2.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Introduction
2.3.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.3.2.2 mRNA Vaccines & Therapeutics Product Information
2.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Translate Bio mRNA Vaccines & Therapeutics Market Share in 2017
2.4 BioNTech
2.4.1 Business Overview
2.4.1.1 BioNTech Description
2.4.1.2 BioNTech Headquarter, Main Business and Finance Overview
2.4.2 BioNTech mRNA Vaccines & Therapeutics Product Introduction
2.4.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.4.2.2 mRNA Vaccines & Therapeutics Product Information
2.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global BioNTech mRNA Vaccines & Therapeutics Market Share in 2017
2.5 Sangamo Therapeutics
2.5.1 Business Overview
2.5.1.1 Sangamo Therapeutics Description
2.5.1.2 Sangamo Therapeutics Headquarter, Main Business and Finance Overview
2.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Introduction
2.5.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.5.2.2 mRNA Vaccines & Therapeutics Product Information
2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Sangamo Therapeutics mRNA Vaccines & Therapeutics Market Share in 2017
2.6 Argos Therapeutics
2.6.1 Business Overview
2.6.1.1 Argos Therapeutics Description
2.6.1.2 Argos Therapeutics Headquarter, Main Business and Finance Overview
2.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Introduction
2.6.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.6.2.2 mRNA Vaccines & Therapeutics Product Information
2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Argos Therapeutics mRNA Vaccines & Therapeutics Market Share in 2017
2.7 In-Cell-Art
2.7.1 Business Overview
2.7.1.1 In-Cell-Art Description
2.7.1.2 In-Cell-Art Headquarter, Main Business and Finance Overview
2.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Introduction
2.7.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.7.2.2 mRNA Vaccines & Therapeutics Product Information
2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global In-Cell-Art mRNA Vaccines & Therapeutics Market Share in 2017
2.8 eTheRNA
2.8.1 Business Overview
2.8.1.1 eTheRNA Description
2.8.1.2 eTheRNA Headquarter, Main Business and Finance Overview
2.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Introduction
2.8.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.8.2.2 mRNA Vaccines & Therapeutics Product Information
2.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global eTheRNA mRNA Vaccines & Therapeutics Market Share in 2017
2.9 Ethris
2.9.1 Business Overview
2.9.1.1 Ethris Description
2.9.1.2 Ethris Headquarter, Main Business and Finance Overview
2.9.2 Ethris mRNA Vaccines & Therapeutics Product Introduction
2.9.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.9.2.2 mRNA Vaccines & Therapeutics Product Information
2.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Ethris mRNA Vaccines & Therapeutics Market Share in 2017
2.10 Tiba Biotechnology
2.10.1 Business Overview
2.10.1.1 Tiba Biotechnology Description
2.10.1.2 Tiba Biotechnology Headquarter, Main Business and Finance Overview
2.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Introduction
2.10.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.10.2.2 mRNA Vaccines & Therapeutics Product Information
2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Tiba Biotechnology mRNA Vaccines & Therapeutics Market Share in 2017
3 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET COMPETITION, BY MANUFACTURER
3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global mRNA Vaccines & Therapeutics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2017
3.4.2 Top 5 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET ANALYSIS BY REGIONS
4.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global mRNA Vaccines & Therapeutics Sales by Regions (2013-2018)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Regions (2013-2018)
4.2 North America mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.5 South America mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA MRNA VACCINES & THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
5.1.2 North America mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
5.1.3 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
5.1.4 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
5.1.5 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
5.2 North America mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
5.2.2 North America mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
5.3 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
5.3.2 North America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
5.4 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
5.4.2 North America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
6 EUROPE MRNA VACCINES & THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
6.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
6.1.3 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.4 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.5 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.6 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.7 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.2 Europe mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
6.2.2 Europe mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
6.3 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
6.3.2 Europe mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
6.4 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
6.4.2 Europe mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC MRNA VACCINES & THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
7.1.3 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.4 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.5 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.6 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA MRNA VACCINES & THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
8.1.2 South America mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
8.1.3 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
8.1.4 Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
8.1.5 Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
8.2 South America mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
8.2.2 South America mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
8.3 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
8.3.2 South America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
8.4 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
8.4.2 South America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA MRNA VACCINES & THERAPEUTICS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
9.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.4 UAE mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.5 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.6 Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.7 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET SEGMENT BY TYPE
10.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Standardization Of Cancer Treatment MRNA Vaccine Sales Growth and Price
10.2.1 Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)
10.2.2 Global Standardization Of Cancer Treatment MRNA Vaccine Price (2013-2018)
10.3 Individualized Cancer Treatment MRNA Vaccine Sales Growth and Price
10.3.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)
10.3.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2013-2018)
10.4 Infectious Disease Treatment MRNA Vaccine Sales Growth and Price
10.4.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2013-2018)
10.4.2 Global Infectious Disease Treatment MRNA Vaccine Price (2013-2018)
10.5 Infection Prevention MRNA Vaccine Sales Growth and Price
10.5.1 Global Infection Prevention MRNA Vaccine Sales Growth (2013-2018)
10.5.2 Global Infection Prevention MRNA Vaccine Price (2013-2018)
11 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET SEGMENT BY APPLICATION
11.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2013-2018)
11.2 Infectious Disease Sales Growth (2013-2018)
11.3 Cancer Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 MRNA VACCINES & THERAPEUTICS MARKET FORECAST (2018-2023)
12.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.2 Europe mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2018-2023)
12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure mRNA Vaccines & Therapeutics Picture
Table Product Specifications of mRNA Vaccines & Therapeutics
Figure Global mRNA Vaccines & Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global mRNA Vaccines & Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of mRNA Vaccines & Therapeutics by Types in 2017
Figure Standardization Of Cancer Treatment MRNA Vaccine Picture
Table Major Manufacturers of Standardization Of Cancer Treatment MRNA Vaccine
Figure Individualized Cancer Treatment MRNA Vaccine Picture
Table Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine
Figure Infectious Disease Treatment MRNA Vaccine Picture
Table Major Manufacturers of Infectious Disease Treatment MRNA Vaccine
Figure Infection Prevention MRNA Vaccine Picture
Table Major Manufacturers of Infection Prevention MRNA Vaccine
Figure mRNA Vaccines & Therapeutics Sales Market Share by Applications in 2017
Figure Infectious Disease Picture
Figure Cancer Picture
Figure Other Picture
Figure United States mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Moderna Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Product
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Moderna Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table CureVac Headquarter, Established, Main Business and Finance Overview (2017)
Table CureVac mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table CureVac mRNA Vaccines & Therapeutics Product
Table CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CureVac mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global CureVac mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Translate Bio Headquarter, Established, Main Business and Finance Overview (2017)
Table Translate Bio mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Translate Bio mRNA Vaccines & Therapeutics Product
Table Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Translate Bio mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Translate Bio mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table BioNTech Headquarter, Established, Main Business and Finance Overview (2017)
Table BioNTech mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table BioNTech mRNA Vaccines & Therapeutics Product
Table BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BioNTech mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global BioNTech mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Sangamo Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Product
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Argos Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Argos Therapeutics mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Argos Therapeutics mRNA Vaccines & Therapeutics Product
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Argos Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Argos Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table In-Cell-Art Headquarter, Established, Main Business and Finance Overview (2017)
Table In-Cell-Art mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table In-Cell-Art mRNA Vaccines & Therapeutics Product
Table In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global In-Cell-Art mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global In-Cell-Art mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table eTheRNA Headquarter, Established, Main Business and Finance Overview (2017)
Table eTheRNA mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table eTheRNA mRNA Vaccines & Therapeutics Product
Table eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global eTheRNA mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global eTheRNA mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Ethris Headquarter, Established, Main Business and Finance Overview (2017)
Table Ethris mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Ethris mRNA Vaccines & Therapeutics Product
Table Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ethris mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Ethris mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Tiba Biotechnology Headquarter, Established, Main Business and Finance Overview (2017)
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Product
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Tiba Biotechnology mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table Global mRNA Vaccines & Therapeutics Price by Manufacturer (2016-2017)
Figure Top 3 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales by Regions (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2013-2018)
Table Global mRNA Vaccines & Therapeutics Revenue by Regions (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2013
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2017
Figure North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure South America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2013
Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2017
Table North America mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
Table North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2013
Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2017
Figure United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table North America mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table North America mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table North America mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table North America mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Table North America mRNA Vaccines & Therapeutics Revenue by Application (2013-2018)
Table North America mRNA Vaccines & Therapeutics Revenue Share by Application (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2016
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2017
Figure Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure France mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure Europe mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure Europe mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table Europe mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table Europe mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Revenue by Application (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Revenue Share by Application (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Countries 2017
Figure China mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure India mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Application (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue Share by Application (2013-2018)
Figure South America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2017
Table South America mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
Table South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure South America mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure South America mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table South America mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure South America mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure South America mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table South America mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table South America mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table South America mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Table South America mRNA Vaccines & Therapeutics Revenue by Application (2013-2018)
Table South America mRNA Vaccines & Therapeutics Revenue Share by Application (2013-2018)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Application (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue Share by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table Global mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table Global mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Figure Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)
Figure Global Standardization Of Cancer Treatment MRNA Vaccine Price (2013-2018)
Figure Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)
Figure Global Individualized Cancer Treatment MRNA Vaccine Price (2013-2018)
Figure Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2013-2018)
Figure Global Infectious Disease Treatment MRNA Vaccine Price (2013-2018)
Figure Global Infection Prevention MRNA Vaccine Sales Growth (2013-2018)
Figure Global Infection Prevention MRNA Vaccine Price (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Figure Global Infectious Disease Sales Growth (2013-2018)
Figure Global Cancer Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global mRNA Vaccines & Therapeutics Sales Forecast by Regions (2018-2023)
Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
Figure Europe Sales mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
Figure South America Sales mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
Table Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2018-2023)
Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2018-2023)
Table Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2018-2023)
Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure mRNA Vaccines & Therapeutics Picture
Table Product Specifications of mRNA Vaccines & Therapeutics
Figure Global mRNA Vaccines & Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global mRNA Vaccines & Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of mRNA Vaccines & Therapeutics by Types in 2017
Figure Standardization Of Cancer Treatment MRNA Vaccine Picture
Table Major Manufacturers of Standardization Of Cancer Treatment MRNA Vaccine
Figure Individualized Cancer Treatment MRNA Vaccine Picture
Table Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine
Figure Infectious Disease Treatment MRNA Vaccine Picture
Table Major Manufacturers of Infectious Disease Treatment MRNA Vaccine
Figure Infection Prevention MRNA Vaccine Picture
Table Major Manufacturers of Infection Prevention MRNA Vaccine
Figure mRNA Vaccines & Therapeutics Sales Market Share by Applications in 2017
Figure Infectious Disease Picture
Figure Cancer Picture
Figure Other Picture
Figure United States mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Moderna Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Product
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Moderna Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table CureVac Headquarter, Established, Main Business and Finance Overview (2017)
Table CureVac mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table CureVac mRNA Vaccines & Therapeutics Product
Table CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CureVac mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global CureVac mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Translate Bio Headquarter, Established, Main Business and Finance Overview (2017)
Table Translate Bio mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Translate Bio mRNA Vaccines & Therapeutics Product
Table Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Translate Bio mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Translate Bio mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table BioNTech Headquarter, Established, Main Business and Finance Overview (2017)
Table BioNTech mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table BioNTech mRNA Vaccines & Therapeutics Product
Table BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BioNTech mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global BioNTech mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Sangamo Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Product
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Argos Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Argos Therapeutics mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Argos Therapeutics mRNA Vaccines & Therapeutics Product
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Argos Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Argos Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table In-Cell-Art Headquarter, Established, Main Business and Finance Overview (2017)
Table In-Cell-Art mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table In-Cell-Art mRNA Vaccines & Therapeutics Product
Table In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global In-Cell-Art mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global In-Cell-Art mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table eTheRNA Headquarter, Established, Main Business and Finance Overview (2017)
Table eTheRNA mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table eTheRNA mRNA Vaccines & Therapeutics Product
Table eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global eTheRNA mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global eTheRNA mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Ethris Headquarter, Established, Main Business and Finance Overview (2017)
Table Ethris mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Ethris mRNA Vaccines & Therapeutics Product
Table Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ethris mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Ethris mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Tiba Biotechnology Headquarter, Established, Main Business and Finance Overview (2017)
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Product
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Tiba Biotechnology mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table Global mRNA Vaccines & Therapeutics Price by Manufacturer (2016-2017)
Figure Top 3 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales by Regions (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2013-2018)
Table Global mRNA Vaccines & Therapeutics Revenue by Regions (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2013
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2017
Figure North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure South America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2013
Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2017
Table North America mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
Table North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2013
Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2017
Figure United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure North America mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table North America mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure North America mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table North America mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table North America mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table North America mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table North America mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Table North America mRNA Vaccines & Therapeutics Revenue by Application (2013-2018)
Table North America mRNA Vaccines & Therapeutics Revenue Share by Application (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2016
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2017
Figure Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure France mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure Europe mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure Europe mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table Europe mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table Europe mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Revenue by Application (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Revenue Share by Application (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Countries 2017
Figure China mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure India mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Application (2013-2018)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue Share by Application (2013-2018)
Figure South America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2017
Table South America mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
Table South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure South America mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure South America mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table South America mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure South America mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure South America mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table South America mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table South America mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table South America mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table South America mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Table South America mRNA Vaccines & Therapeutics Revenue by Application (2013-2018)
Table South America mRNA Vaccines & Therapeutics Revenue Share by Application (2013-2018)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Application (2013-2018)
Table Middle East and Africa mRNA Vaccines & Therapeutics Revenue Share by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales by Type (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales Share by Type (2013-2018)
Table Global mRNA Vaccines & Therapeutics Revenue by Type (2013-2018)
Table Global mRNA Vaccines & Therapeutics Revenue Share by Type (2013-2018)
Figure Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)
Figure Global Standardization Of Cancer Treatment MRNA Vaccine Price (2013-2018)
Figure Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)
Figure Global Individualized Cancer Treatment MRNA Vaccine Price (2013-2018)
Figure Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2013-2018)
Figure Global Infectious Disease Treatment MRNA Vaccine Price (2013-2018)
Figure Global Infection Prevention MRNA Vaccine Sales Growth (2013-2018)
Figure Global Infection Prevention MRNA Vaccine Price (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales Share by Application (2013-2018)
Figure Global Infectious Disease Sales Growth (2013-2018)
Figure Global Cancer Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global mRNA Vaccines & Therapeutics Sales Forecast by Regions (2018-2023)
Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
Figure Europe Sales mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
Figure South America Sales mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
Table Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2018-2023)
Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2018-2023)
Table Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2018-2023)
Table Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
